Krystal Biotech
KRYS
KRYS
140 hedge funds and large institutions have $1.35B invested in Krystal Biotech in 2021 Q4 according to their latest regulatory filings, with 48 funds opening new positions, 56 increasing their positions, 22 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
24% more funds holding
Funds holding: 113 → 140 (+27)
4.16% more ownership
Funds ownership: 73.36% → 77.52% (+4.2%)
15% less call options, than puts
Call options by funds: $17.1M | Put options by funds: $20.3M
Holders
140
Holding in Top 10
4
Calls
$17.1M
Puts
$20.3M
Top Buyers
| 1 | +$92.4M | |
| 2 | +$33.2M | |
| 3 | +$14M | |
| 4 |
BBA
Baker Bros. Advisors
New York
|
+$14M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$9.44M |
Top Sellers
| 1 | -$11.3M | |
| 2 | -$7.31M | |
| 3 | -$5.89M | |
| 4 |
NIP
Nicholas Investment Partners
Rancho Santa Fe,
California
|
-$4.59M |
| 5 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$3.79M |